Arrowhead Pharmaceuticals is hiring for 35 jobs on Simplify. Start your career today.

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

RNAi-based gene-silencing therapeutics

Biotechnology

Work Here? Claim Your Company

Company Overview
Arrowhead Pharmaceuticals stands out in the biopharmaceutical industry through its focused application of RNA interference (RNAi) mechanisms to develop targeted therapies for genetic diseases, exemplified by its candidate plozasiran aimed at reducing ApoC3 protein levels to manage severe hypertriglyceridemia. The company's proprietary TRiM platform demonstrates a competitive edge by enabling tissue-specific gene silencing, which has shown promise in early clinical trials, such as the AROAPOC3-2001 study, to improve lipid levels safely and effectively. Arrowhead's approach to drug development not only streamlines manufacturing and potentially reduces costs but also positions the company as a leader in RNAi therapeutics, with ongoing research that could transform treatment paradigms for patients with lipid disorders.
Biotechnology

Company Stage

N/A

Total Funding

$899.9M

Founded

2004

Headquarters

Pasadena, California

Growth & Insights
Headcount

6 month growth

9%

1 year growth

27%

2 year growth

60%